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MYOCARDIAL 
PERFORMANCEIN ELDERLY 
PATIENTS AFTER 
CARDIOPULMONARY 
BYPASS IS SUPPRESSED BY 
TUMOR NECROSIS FACTOR 
The aim of this study was to determine whether elderly patients (aged >65 
years, n = 20) in comparison with younger patients (aged _<55 years, n = 
23) demonstrate a different biochemical and hemodynamic response to 
coronary artery bypass operations. In the elderly group, we calculated a
smaller body surface area (p < 0.01) than that in the younger group, and 
more female patients were included in this group (p < 0.05). During 
cardiopulmonary b pass, the elderly had higher endotoxin plasma concen- 
trations (p < 0.01) than the younger patients, and significantly more 
circulating tumor necrosis factor-alpha was found after operation (p < 
0.04). In the intensive care unit, the elderly patients had a significantly 
higher pulmonary capillary wedge pressure (p < 0.001), a higher mean 
pulmonary artery pressure (p < 0.01), and a lower calculated left ventric- 
uiar stroke work index (p < 0.05). Multivariate analysis for the postoper- 
ative outcome showed that the intergroup differences in tumor necrosis 
factor-alpha, mean pulmonary artery pressure, and pulmonary capillary 
wedge pressure could be xplained mainly by the difference in age between 
the groups and that he calculated left ventricular stroke work index 
difference could be explained by the difference in circulating tmnor necrosis 
faCtor-alpha levels. Thus in elderly patients higher circulating endotoxin 
and tumor necrosis factor-alpha concentrations were detected than in 
younger patients, which clinically resulted in a suppressed myocardial 
performance. (J THORAC CARDIOVASC SURG 1995;110:1663-9) 
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T umor necrosis factor-alpha (TNFo 0 is a strong mediator of inflammation in human beings and 
animals. Administration of TNFa  to human beings 
and animals elicits manifestations of sepsis and 
septic shock, including fever, acidosis, leukopenia, 
histopathologic evidence of organ failure, and 
death.l, 2 TNFa-induced hemodynamic changes in- 
clude elevated cardiac output, tachycardia, and de- 
creased systemic vascular resistance. 2 Recently, TNFo~- 
induced negative inotropic effects on the heart were 
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described that lead to an impaired myocardial per- 
formance. 3 Several studies reported TNFo~ in the 
circulation of patients after cardiac operations, 4' 5 
suggesting that this may play a pivotal role in 
postoperative complications after cardiac opera- 
tions. 
After cardiac operations with cardiopulmonary 
bypass (CPB) a sepsislike syndrome may develop, 
induced by a systemic inflammatory response. 6 The 
clinical manifestations of this sepsislike syndrome 
resemble the endotoxin- and TNF~-induced re- 
sponse in human beings and animals. ~'7 TNFa 
synthesis may be induced by complement activation 
or endotoxemia, which have both been reported to 
occur during CPB. 4'6'8-1° Experimental endotox- 
emia in human beings induced an inflammatory 
response with early TNFc~ production] Recently, we 
reported that endotoxemia during CPB is induced 
by perfusion-related factors and not by contamina- 
tion of the supplied fluids. 1° Endotoxemia was most 
severe in patients (1) with the largest drop in oncotic 
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Table I. Patient characteristics, urgical data, fluid 
balance, and vasoactive medications 
P 
Age <-55 yr Age >-65 yr Value 
Age (yr) 50 +_ 1.5 69 -+ 1.3 <0.001 
No. of patients 23 20 
Gender (female/ 1/22 5/15 <0.05* 
male) 
B Surface A (m 2) 2.06 +_ 0.04 1.94 _+ 0.05 <0.005 
Height (cm) 178 +_ 3.0 174 _+ 3.2 <0.05 
Body weight (kg) 86 _+ 3.8 79 +_ 3.9 <0:05 
LVEDP (ram Hg) 12 + 2.7 13 _+ 1.9 NS 
CPB time (mins) 99 +_ 11 108 + 17 NS 
Crossclamp time 66 +_ 9 68 +_ 12 NS 
(mins) 
No. of distal arias- 3.2 -+ 0.5 3.6 _+ 0.8 NS 
tomoses 
Fluid balancet (L) 4.2 +_ 1.1 4.1 + 1.0 NS 
Diuresist (L) 7.0 _+ 1.2 6.2 + 1.0 NS 
Blood losst (L) 1.8 +_ 0.4 1:7 + 0.6 NS 
Dopamine? (~g) 378 -+ 99 352 -+ 99 NS 
Nitroglycerin? (mg) 20 _+ 9.4 25 + 7.8 NS 
Data are presented as mean +_95% confidence interval of the mean. 
LVEDP, LV end-diastolic pressure; NS, not significant, 
*Determined by Fisher's exact test. 
?From induction of anesthesia until 18 hours after arrival in the ICU. 
pressure during CPB, (2) who had a vasoconstriction 
reaction on onset of CPB, and (3) with long duration 
of CPB. Elderly patients might have a more sensitive 
reaction to these factors and therefore might be 
more at risk for development of endotoxemia. This 
would be in agreement with statistical evaluations 
that show that the age of the patient is one of the 
major risk factors in predicting mortality and mor- 
bidity in cardiac operations. TM 12 After cardiac oper- 
ations, the principal causes of death in elderly 
patients were cardiac related. 12 
The aim of this study was to determine whether 
the biochemical and hemodynamic responses to 
CPB in elderly patients are different from those in 
younger patients. Therefore we measured TNF~ 
levels and hemodynamic parameters and estimated 
the myocardial performance of patients 55 years old 
or younger and 65 years old or older during CPB 
and during the intensive care unit ( ICU) stay. In a 
subpopulation, we verified whether these parame- 
ters were associated with circulating endotoxin con- 
centrations. 
Material and methods 
Patients and study design. Forty-three patients who 
underwent nonurgent coronary artery bypass grafting 
were selected from a databank that served several clinical 
studies during the past 2 years. The inclusion criteria for 
these studies were age between 45 and 75 years, left 
ventricular (LV) end-diastolic pressure less than 20 mm 
Hg, ejection fraction greater than 40%, and aspirin ther- 
apy stopped more than 3 days before operation. The total 
group (n = 85) was divided into two age groups according 
to the 25th and the 75th percentiles: patients younger than 
or equal to age 55 years (n = 23) and patients older than 
or equal to age 65 years (n -- 20). None of the patients had 
major organ dysfunctions before coronary artery bypass 
grafting or perioperative myocardial infarctions. All stud- 
ies were done at the Free University Hospital, Amster- 
dam, The Netherlands and were approved by the local 
medical ethical committee. All patients gave informed 
consent for the specific study. 
Technique of anesthesia nd CPB. On the day of the 
operation, patients received their usual early morning 
dose of antianginal medication and 5 mg lorazepam. 
Anesthesia was induced with intravenous fentanyl 30 
/zg/kg, pancuronium bromide 0.1 mg/kg, and diazepam 0.1 
mg/kg and maintained by supplemental doses of these 
drugs. After endotracheal intubation was accomplished, 
patients received assisted ventilation to normocapnia with 
an oxygen-air mixture. The Standard perfusion protocol 
aimed at a hematocrit value of 22% to 23% during CPB. 
CPB was done with moderate systemic hypothermia (28 ° 
to 30 ° C), nonpulsatile flow (2.2 to 2.4 L/min per square 
meter) and cold high-potassium crystalloid cardioplegia 
(4 ° C). The CPB circuit consisted of a closed venous 
reservoir, a roller pump, and a membrane oxygenator 
(Ultrox-1, Avecor, Plymouth, Minn., or Univox, Baxter 
Healthcare Corp., Irvine, Calif.) with an arterial ine filter 
and polyvinyl chloride tubing. A standard cannulation 
technique was used with a cannula in the ascending aorta 
and the right atrium (two-stage venous cannula). Patients 
were weaned from CPB with dopamine 0.5 /xg • 
kg 1. rain-1 and nitroglycerin 0.5 /xg.kg -1.min -1 or 
higher doses if necessary. After termination of CPB, 
heparin was neutralized with an equal dose of protamine 
sulfate. 
Sample scheme and biochemical assays. Blood sam- 
ples were taken from the radial artery or the arterial ine 
of the extracorporeal circuit before induction of anesthe- 
sia (SO), 10 minutes after the start of CPB (S1), 10 minutes 
after removal of the aortic crossclamp ($2), at cessation of 
CPB ($3), 1 hour after the patient arrived in the ICU ($4), 
4 hours after arrival in the ICU ($5), and 18 hours after 
arrival in the ICU ($6). Blood samples for TNFc~ deter- 
mination were taken at points SO, $3, $4, $5, and $6, and 
endotoxin samples were taken at points SO, $1, $2, $3, $4, 
and $6. Blood samples for TNFc~ determination were 
collected in 5 ml citrate-anticoagulated ubes. The sam- 
ples were immersed in ice immediately after collection 
and processed within 1 hour. Platelet-poor plasma was 
prepared by centrifugation at4 ° C for 10 minutes at 3000 
rpm. The samples were stored at -70 ° C. 
TNFoc TNFc~ concentrations were determined with an 
immunoradiometric assay (Medgenix, Brussels, Belgium). 
The TNFc~ immunoradiometric assay has a detection limit 
of 5 ng/L and intraassay and interassay coefficients of 
variance of 6% and 7%, respectively, at 66 ng/L. The 
TNFc~ data presented were not corrected for hemodilu- 
tion. 
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Endotoxin. Endotoxin concentrations were available in 
a subpopulation of 11 patients: 6 patients in the younger 
group and 5 patients in the elderly group. Endotoxin levels 
were estimated with the chromogenic Limulus assay 
(Coatest Endotoxin, Kabi-Chromogenix, MOlndal, Swe- 
den, which included LimuIus amebocyte lysate prepara- 
tions produced by Whittaker Bioproducts, Inc., Walkers- 
ville, Md.) as described before. 13 Blood for the Limulus 
assay was collected under pyrogen-free conditions in 
monovettes (Sarstedt, Ntimbrecht, Germany), containing 
pyrogen-free heparin (Thromboliquine, Organon, Oss, 
The Netherlands) at a final concentration of 30 IU.  m1-1, 
and the tubes were immediately immersed in crushed ice. 
Platelet-rich plasma was prepared by centrifugation for 10 
minutes at 190 g and 4 ° C and was stored in duplicate 
portions in polystyrene tubes (Falcon 2063, Oxnard, 
Calif.) at -70 ° C. Endotoxin concentrations are given in 
endotoxin units per milliliter platelet-rich plasma 
(EU. ml-i). The detection limit was 0.036 EU. m1-1. The 
clinical decision limit for an endotoxin-positive sample was 
0.060 EU. ml -a. Endotoxemia was defined as the area under 
the curve of endotoxin from samples SO through $3 (before 
and during CPB). The endotoxin data presented were not 
corrected for hemodilution. With the endotoxin standard 
presently used 0.012 EU corresponds to 1 pg. 
Hemodynamic parameters and volume management. 
Hemodynamic parameters were assessed with the aid of a 
radial artery catheter and a Swan-Ganz catheter (Baxter 
Healthcare Corp., Edwards Division, Santa Ana, Calif.). 
The heart rate, mean arterial pressure, central venous 
pressure, pulmona12y artery pressure, pulmonary capillary 
wedge pressure, and cardiac output (thermodilution 
method) were measured after induction of anesthesia (SO) 
and at 1 hour (S4), 4 hours (S5), and 18 hours ($6) after 
the patient arrived in the ICU. The following parameters 
were calculated: cardiac index = cardiac output/body 
surface area (BSA); stroke volume index = (cardiac 
inde~heart ate) × 1000; LV stroke work index = (mean 
arterial pressure - pulmonary capillary wedge pressure) 
× stroke volume index × 0.0136; and right ventricular 
stroke work index = (pulmonary artery pressure - central 
venous pressure) × stroke volume index × 0.0136. The 
fluid balance was defined as fluid administration - (di- 
uresis + blood loss) and was calculated from induction of 
anesthesia until 18 hours after operation. The distribution 
of insensible fluid losses was considered even among both 
groups and not included in the calculation. 
Statistics. Statistical analysis was done with the use of 
Statview SE + Graphics computer software (Abacus 
Concepts, Inc., Berkeley, Calif.). An unpaired two-tailed 
Student's t test was done to determine differences between 
groups, except for the endotoxin data. Differences in 
endotoxin concentrations were determined with the 
Mann-Whitney U test. Differences between the ratio of 
female to male patients between the groups were deter- 
mined with Fisher's exact test. To analyze changes within 
each group, one-factor analysis of variance for repeated 
measures was done, supplemented with the Scheff6 post 
hoc test. Additionally, two-factor analysis of variance for 
repeated measures was used to assess intergroup compar- 
isons and group-time interactions during ICU stay. A 
nonsignificant group-time interaction indicates that the 
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Fig. 1. Circulating TNFc~ concentrations in 20 elderly 
patients (aged >-65 years) (open squares) and 23 younger 
patients (aged --55 years) (solid squares) during and after 
cardiac operation. During ICU stay (arrows), two-factor 
analysis of variance for repeated measures yielded inter- 
group differences in circulating TNFc~ concentrations. 
Data are presented as means -+95% confidence interval of 
mean. *p < 0.05 compared with preoperative sample; 
#p < 0.05 compared with previous ample. 
difference in hemodynamics in the ICU is explained by 
difference in age of the patient groups and this difference 
would not change as a result of time. To analyze the 
influence of other parameters (besides age), multivariate 
analysis was done for the significantly different hemody- 
namic parameters and circulating TNFc~ levels during the 
ICU stay. Regression analysis was done to determine the 
correlation between the area under the curve of endotoxin 
during CPB and the mean peak of TNFa levels during the 
ICU stay. In all cases a two-sided p value less than 0.05 
was considered to be significant. Data are presented as 
means _+95% confidence intervals of the mean, unless 
stated otherwise. 
Results 
The difference in age between the younger and 
elderly patients groups was 19 years (Table I). The 
elderly patients were smaller and lighter and had 
therefore a smaller BSA than the younger patients. 
Significantly more women were enrolled in the 
elderly group. There were no differences between 
the patient groups concerning LV end-diastolic 
pressure, number of distal anastomoses, or duration 
of crossclamping and CPB. Also, no differences 
were found in fluid balance, diuresis, blood loss, or 
use of vasoactive medication. 
Peak levels of  TNFo~ were reached within the first 
hours after patient arrival in the ICU (Fig. 1). 
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Fig. 2. Circulating endotoxin concentrations in six younger patients (aged -<55 years) and five elderly 
patients (aged ->65 years) during and after cardiac operation. Significant difference was observed after 
crossclamp removal (X-off, p < 0.05) between elderly and younger patients (Mann-Whitney test). 1 Day PO, 
18 hours after arrival at ICU. 
Intragroup differences were observed in both 
groups. Circulating TNFoz levels rose significantly 1 
hour after patient arrival in the ICU and remained 
elevated at 4 hours in the ICU. At measurement on 
the first postoperative day TNF~ concentrations had 
returned to baseline values. An intergroup differ- 
ence was observed uring the first hours of the ICU 
stay (p = 0.04, no interaction with time). Younger 
patients had mean peak levels of TNFo~ (mean of 2 
measurements at 1 and 4 hours in the ICU) of 28 _+ 
6 ng. L -1 and elderly patients had corresponding 
levels of 47 + 15 ng. L -1. 
In 10 of 11 patients endotoxemia developed ur- 
ing the cardiac operation (Fig. 2). None of the 
patients had detectable endotoxin concentrations i  
the blood before induction of anesthesia. In three of 
five elderly patients endotoxin concentrations higher
than 0.060 EU-m1-1 were observed immediately 
after the onset of CPB (Fig. 2, right), whereas this 
endotoxin concentration was observed at that point 
in one of six younger patients not significant, p = 
0.06, Fisher's exact est) (Fig. 2, left). After removal 
of the aortic crossclamp a significant difference was 
observed between the groups (p < 0.05). The extent 
of endotoxemia was more pronounced in the elderly 
patients (elderly patients 0.443 EU- h. m1-1, range 
0.127 to 0.797; younger patients 0.066 EU 
hr. ml-1; range 0 to 0.162;p = 0.02). There was no 
significant correlation between the area under the 
curve of endotoxin and mean peak of TNFo~ levels in 
the corresponding patients (r z = 0.34, p = 0.06). 
Changes in the measured and calculated hemody- 
namic parameters of the young and elderly patient 
groups are depicted in Fig 3, A and B, respectively. 
The course of values for mean arterial pressure is 
not presented because the mean arterial pressure is 
one of the targets of treatment in the ICU and, 
therefore, no intragroup changes were observed in 
either group. Intragroup differences were found in 
all presented parameters except mean pulmonary 
artery pressure. Heart rate and cardiac index in- 
creased in both younger and elderly patients in the 
ICU. The central venous pressure and the pulmo- 
nary capillary wedge pressure significantly dropped 
after patient arrival at the ICU in the younger 
patients, whereas in the elderly both pressures re- 
mained unchanged. In the younger patients, the 
stroke volume index and both the left and right 
ventricular stroke work indices increased in the 
ICU, whereas in the elderly only an increase in LV 
stroke work index was observed 18 hours after 
arrival at the ICU and all other parameters re- 
mained unchanged. We determined intergroup dif- 
ferences in the measured hemodynamic parameters 
in the ICU. In the elderly patients, a higher pulmo- 
nary capillary wedge pressure (p = 0.001, no inter- 
action with time) and a higher mean pulmonary 
artery pressure (p = 0.006, no interaction with time) 
were observed compared with these valves in the 
younger patient group (Fig. 3, A). Among all calcu- 
lated hemodynamic parameters, we found that the 
LV stroke work index was significantly ower in the 
elderly patients than in the younger patients (p = 
0.04, no interaction with time). No significant inter- 
group differences were observed in central venous 
pressure, pulmonary artery pressure, heart rate, 
cardiac index, stroke volume index (p = 0.06, no 
interaction with time), or right ventricular stroke 
work index. 
To analyze whether the intergroup differences 
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Fig. 3. Hemodynamic profile of lderly (open squares) and younger (solid squares) patients during ICU 
stay. A, Measured hemodynamic parameters; B, calculated parameters. During ICU stay (arrows), 
two-factor analysis of variance for repeated measures yielded intergroup differences inpulmonary capillary 
wedge pressure, mean pulmonary artery pressure, and LV stroke work index. *:p < 0.05 compared with 
preoperative sample. 
observed in the ICU could indeed be explained by 
the difference in age between the groups, multivari- 
ate analysis of variance was done with age and other 
significantly different factors including BSA,gender, 
and TNFc~ level (Table II). The BSA and TNFc~ 
were divided into two categories according to the 
median value of the population: low TNFo~, less than 
28.2 ng. L -1 (n = 21), and high TNFa, 28.2 ng. L -1 
or greater (n = 22), and low BSA, less than 1.99 m 2 
(n = 20), and high BSA, 1.99 m s or greater (n = 23). 
The multivariate analysis showed that the inter- 
group difference in TNF~ level and mean pulmo- 
nary artery pressure could only be explained by the 
difference in age between the groups and not by the 
difference in gender or BSA. The intergroup differ- 
ence in pulmonary capillary wedge pressure, how- 
ever, was explained by the difference inboth age and 
BSA, independently (p = 0.50 for the interrelation 
between age and BSA for pulmonary capillary 
wedge pressure). The intergroup difference in LV 
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Table II. Multivariate analysis for TNFa level and 
hemodynamic parameters in the ICU 
p Values 
Parameter TNFa/age gender~age BSA/age 
TNFo~ level - -  0,28/0.03 0.82/0.03 
Mean PAP 0.34/0,003 0,84/0.003 0.09/0.01 
PCWP 0.66/0,03 0,76/0.02 0,04/0.005* 
LV SWI 0.00i/0.41 0.09/0.31 0.36/0.29 
P values of two-factor analysis of variance. TNFc~ catagories: low TNFa, 
less than 28.2 rig. L -1, and high TNFa, 28.2 ng. L -1 or greater; BSA 
catagories: small BSA, less than 1.99 m 2, and large BSA, 1.99 m 2 or 
greater, PAP, Pulmonary artery pressure; PCWP, pulmonary capillary 
wedge pressure; SW/, stroke work index. 
*No interaction between BSA and age, p = 0.50. 
stroke work index was explained by the difference in 
TNFo~ level and not by age, gender, or BSA. The 
area under the curve of endotoxin was not included 
in the two-factor analysis of variance because of the 
low number of patients with available endotoxin 
data. 
Discussion 
Elderly and younger patients demonstrated a 
different biochemical nd hemodynamic response to 
CPB. A more pronounced endotoxemia developed 
in elderly patients during CPB and higher circulat- 
ing TNFoL concentrations were detected in the ICU. 
The significantly higher TNFoL plasma concentra- 
tions in the elderly patients were probably induced 
by the more pronounced endotoxemia during CPB. 
The higher circulating TNFc~ concentrations were 
associated with a lower calculated LV stroke work 
index, indicating that the high TNFc~ plasma con- 
centrations might be the causative factor of the 
impaired LV performance. 
A clear difference in hemodynamics was mea- 
sured between elderly and younger patients in the 
ICU, although no differences were observed in fluid 
balance, blood loss, diuresis, or use of vasoactive 
medication. In elderly patients significantly higher 
pulmonary capillary wedge pressures and mean pup 
monary artery pressures were determined compared 
with respective valves in younger patients. No intra- 
group changes were determined in the mean pulmo- 
nary artery pressures and only a drop in pulmonary 
capillary wedge pressures was observed in the 
younger patients after arrival at the ICU. However, 
the levels of both hemodynamic parameters were 
clearly different between younger and elderly pa- 
tients. 
The statistical analysis of the calculated hemody- 
namic parameters in the ICU showed clear intra- 
group differences in stroke volume index and LV 
stroke work index. Significant increases in stroke 
volume index and LV stroke work index were ob- 
served in the younger patients, whereas in the 
elderly patients no or small changes from baseline 
valves were determined. Heart rate and cardiac 
index increased equally in the ICU, but a small, 
nonsignificant, intergroup difference in cardiac in- 
dex was observed in the ICU, which caused a clear 
trend in the intergroup difference in the stroke 
volume index (p = 0.06). In the younger patients, 
the combination of a higher stroke volume index 
and a lower pulmonary capillary wedge pressure 
resulted in the higher calculated LV stroke work 
index in the ICU than that in the elderly. Addition- 
ally, the RV stroke work indices in both groups were 
equal in the ICU. These observations, combined 
with the equal increases in heart rate, cardiac index, 
and fluid balance, indicate that in elderly patients 
the myocardial performance is suppressed. 
Significant differences were determined in the 
demographic parameters of weight, height, BSA, 
and gender of the patients groups. To analyze the 
influence of these parameters, besides age, on the 
postoperative outcome multivariate analysis of vari- 
ance was done. Before we entered TNFo~ level into 
the analysis, we showed that the age of patients and 
not gender or BSA explained the difference in 
TNFo~ in the ICU. The multivariate analysis howed 
that the difference in age of the patients also ex- 
plained the mean pulmonary artery pressures in the 
ICU, whereas both BSA and age explained the 
difference in pulmonary capillary wedge pressures in 
the ICU. The differences in circulating TNFo~ levels 
within the first hours in the ICU did not explain the 
outcome in these measured parameters. However, 
for the LV stroke work index the circulating TNFc~ 
levels explained the intergroup difference, whereas 
no significant influences of either age, gender, or 
BSA could be determined. Thus the difference in 
age between the groups resulted in higher circulat- 
ing TNFoL levels in elderly patients in the ICU, 
which subsequently resulted in a lower LV stroke 
work index. The TNFoMnduced clinical effects re- 
sulted in a diminished LV contractility in the ICU. 
TNFoz itself is a strong mediator of patholog- 
ic changes uch as hypotension, tachycardia, nd im- 
paired organ perfusion. Also, TNFc~ induces changes 
in myocardial performance. Although TNFc~ induces 
an increase in heart rate and cardiac index, several 
studies have documented epression of myocardial 
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performance after TNFa challenge. 2' 14 Reversible 
LV dysfunction was observed after 6 hours and 
persisted for 24 to 48 hours after injection with 
recombinant TNFo~ in conscious dogs. The direct 
negative inotropic effect of TNFo~ on isolated ham- 
ster papillary muscles is dependent on a secondary 
messenger. Nitric oxide (also known as endotheli- 
urn-derived relaxing factor) was described as the 
secondary mediator that inhibited the contractility 
of the mammalian heart in vitro. 2 Our results sup- 
port the in vitro data; the suppressed calculated LV 
stroke work index implies an inhibited contractility 
of the heart. 
TNFo~ Synthesis can be induced by several trig- 
gers. Endotoxin was reported to be a strong inducer 
of cytokine production. 7 Indeed, in a subpopulation 
of 11 patients, a significantly more pronounced endo- 
toxemia was observed in the elderly patients. The 
trend in the correlation between endotoxemia and the 
area under the curve of TNFc~ level, with an r 2 valve of 
0.34 and a probability of 0.06, seemed to support he 
hypothesis of endotoxin-induced TNFc~ production 
after CPB. These facts suggest hat the difference in 
circulating TNFo~ levels was likely induced by endo- 
toxin. In a previous tudy, we described three perfu- 
sion-related factors that caused severe endotoxemia 
after CPB. 1° Apparently, elderly patients have hemo- 
dynamically inadequate responses to low oncotic 
prime solutions, severe hemodilution, and hypother- 
mia during CPB and have a greater isk of endotox- 
emia than younger patients. 
In conclusion, in this study we showed that elderly 
patients had higher plasma concentrations of TNFo~ 
than younger patients after cardiac operation. The 
higher TNFa concentrations were most likely in- 
duced by high plasma endotoxin concentrations. 
The clinical effect of high TNFa levels was observed 
in a suppression of the LV performance in elderly 
patients in the ICU. This indicates that with the 
current CPB technique lderly patients are at higher 
risk for the development of postoperative cardiac- 
related complications than younger patients. This is 
of great importance, because with increasing life ex- 
pectancy and an increasing number of elderly patients 
undergoing coronary artery bypass grafting, morbidity 
and mortality will increase. Improvements in perfusion 
techniques will therefore be required to reduce these 
inflammatory eactions associated with CPB. 
We thank I. Y. Koen and K. Joop for technical assis- 
tance in performing the endotoxin assays. 
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